Orion Biotechnology
Orion Biotechnology is an Ontario, Canada-based company developing therapeutics for targeting G Protein-Coupled Receptors (GPCRs).
1
Funding Rounds
$11.5m
Money raised
Funding series
Funding Series Analysis
The company Orion Biotechnology has raised a total of $11.5m in funding over 1 rounds.
Key Insights:
- Orion Biotechnology Series A round, June 2021: $11.5m
Orion Biotechnology Series A round, June 2021
$11.5m
Industries
Orion Biotechnology is active in the following industries: